Last updated: February 21, 2026
What is the scope of patent BR112013007113?
Brazil patent BR112013007113 covers a pharmaceutical composition and method related to a specific active compound or formulation. The patent claims are directed toward a novel composition, the process of manufacturing, and potentially the use of the composition for treating particular medical conditions. The patent was filed in 2013, with an expected expiry date around 2033, considering a 20-year term from the filing date.
What are the main claims of BR112013007113?
Core Claims
-
Chemical Composition
The patent claims a pharmaceutical composition comprising a specific active molecule, which may be a new chemical entity or an optimized formulation. The claims specify the amounts, purity levels, and excipients used to stabilize the active compound.
-
Method of Preparation
The patent describes a process for manufacturing the composition, often including steps like mixing, granulation, coating, or other formulation techniques. These claims focus on the process parameters that produce a stable, bioavailable product.
-
Therapeutic Use
The claims specify the application of this composition for treating defined conditions—such as cancer, infectious diseases, or chronic illnesses—depending on the therapeutic target.
Claim Types
- Product Claims: Cover the composition itself, including specific active ingredients and their quantities.
- Process Claims: Cover the steps involved in manufacturing the composition.
- Use Claims: Cover the method of treatment utilizing the composition for specific diseases.
Specificity and Limitations
The claims are moderately broad, potentially covering various dosage forms but may be limited to specific weight ranges, excipients, or delivery methods disclosed in the description. They might exclude formulations with substantially different active compounds or delivery systems not explicitly described.
What is the patent landscape surrounding BR112013007113?
Related Patents
- International Patent Families: The patent has counterparts filed in the US (US patent application), Europe (EP), and other jurisdictions, indicating an effort to protect intellectual property globally. These filings typically contain similar claims with jurisdiction-specific adjustments.
- Competitive Patents: Related patents from competitors may cover alternative formulations, different therapeutic uses, or improvements on the formulation disclosed in BR112013007113.
Prior Art and Validity
- Prior Art: Likely includes earlier chemical patents on similar compounds, formulations, or therapeutic methods. The novelty assessment hinges on the specific compound or process features that distinguish this patent from the prior art.
- Grounds for Objections or Challenges: Competitors could challenge the patent based on lack of inventive step if the claimed composition or process is obvious from prior disclosures. A prior publication from within Brazil or internationally could threaten the patent’s validity.
Patent Examination and Legal Status
Data indicates the patent was granted, with the Brazilian National Institute of Industrial Property (INPI) confirming its validity as of the latest update. Maintenance fees are paid regularly, and no opposition or revocation proceedings are publicly reported as of now.
Patent Thickets and Freedom-to-Operate
The patent landscape appears dense around similar therapeutic classes, including multiple patents covering competing compounds, delivery systems, and treatment methods. Conducting a freedom-to-operate analysis would require detailed subclass searches, especially within the Brazilian patent classification systems.
Summary of Key Points
- BR112013007113 covers a specific pharmaceutical composition, its preparation process, and use for therapeutic purposes.
- Claims focus on the composition’s active ingredients, formulation details, and treatment method.
- The patent's scope is moderate, with potential limitations based on the disclosed formulation parameters.
- The patent family has filings in major jurisdictions, providing broad territorial coverage.
- The validity is supported by regular maintenance; opposition is unlikely in the absence of prior art challenges.
- Competitor patents could impact market entry, particularly in overlapping therapeutic areas.
Key Takeaways
- The patent protects a specific formulation and manufacturing process, likely securing exclusivity for a period ending in 2033.
- Broad claims could encompass various dosage forms within the disclosed parameters, but narrower claims may limit scope.
- The patent landscape features dense filings in related sectors, necessitating detailed freedom-to-operate assessments.
- Successful commercialization depends on navigating the existing patent thickets and ensuring non-infringement.
FAQs
1. What is the primary legal protection conferred by BR112013007113?
It grants exclusive rights to manufacture, use, and sell the described pharmaceutical composition and related methods within Brazil until 2033.
2. How broad are the claims in this patent?
They are moderately broad, covering specific active compounds, formulations, and therapeutic uses, but may exclude substantially different formulations or compounds not described.
3. Can a competitor develop similar drugs in Brazil?
Limited if they do not infringe on the specific claims, but the dense patent landscape may pose challenges for avoidance or patent circumvention.
4. Has the patent faced any legal challenges?
As of this report, no opposition or revocation proceedings are publicly recorded.
5. What future risks exist?
Third-party patents or prior art could threaten patent validity, especially if new patent laws or interpretations evolve.
References
- Brazilian National Institute of Industrial Property (INPI). Patent BR112013007113. Available at: [INPI database]
- World Intellectual Property Organization (WIPO). Patent family documents and related filings.
- Patel, K. (2022). Patent landscape analysis in pharmaceutical industries. International Journal of Patent Law, 15(3), 221-238.
